December 2, 2023 Comments Off on New patent for Glaxo Grp drug BREO ELLIPTA Posted in: Patent Added Annual Drug Patent Expirations for BREO+ELLIPTA Breo Ellipta is a drug marketed by Glaxo Grp Ltd and is included in one NDA. It is available from two suppliers. There are…
The post New patent for Glaxo Grp drug BREO ELLIPTA appeared first on DrugPatent…
November 30, 2023 Comments Off on New patent for United Therap drug TYVASO Posted in: Patent Added Annual Drug Patent Expirations for TYVASO Tyvaso is a drug marketed by United Therap and is included in two NDAs. It is available from one supplier. There are ten patents…
The post New patent for United Therap drug TYVASO appeared first on DrugPatentWa…